Nutraceutical CDMO Market

Future Market Insights

Key Insight

The nutraceutical CDMO market is projected to grow from USD 37,731.7 million in 2025 to USD 65,064.8 million by 2035, at a CAGR of 5.5%. Tablets & Capsules will dominate with a 39.4% market share, while manufacturing and packaging will lead the services segment with a 33.7% share.

October 07, 2025

Anurag Sharma

300 Pages

Cite this Report

Nutraceutical CDMO Market

https://www.futuremarketinsights.com/reports/nutraceutical-cdmo-market

License

Buy Now

Summary ToC Companies

Key Players

Aenova Group
BASF
Iprona Group
Nutraceuticals International Group
Nutrilo GmbH
Pharmaceutical Company
Pharmavite LLC
ProTec Nutra Ltd
Recipharm AB
Softigel (A Division Of Procaps Group)
Vitakem Nutraceutical Inc

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Nutraceutical CDMO Market

Key Players

Similar Industry Reports